MYLAN 233 (Efavirenz 600 mg)

Pill imprint MYLAN 233 has been identified as Efavirenz 600 mg.

Efavirenz is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Efavirenz

Imprint:

MYLAN 233

Strength:

600 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

NNRTIs

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.